Position on key issues

In our focus to help patients with serious diseases, we have developed clear positions on important policies and topics related to healthcare, regulatory, intellectual property and pricing. Learn more about our positions below.

Animal welfare

We uphold the highest standards of ethical responsibility for the care and welfare of research animals while contributing to the discovery and development of innovative medicines that help patients prevail over serious diseases.

Antimicrobial resistance (AMR) position

Antimicrobial Resistance (AMR) is a natural process that occurs when microorganisms such as bacteria, viruses, fungi and parasites develop the ability to survive against the drugs designed to kill them. 

Anti-bribery and anti-corruption

ww5 is committed to conducting business in compliance with international anti-bribery and anti-corruption (ABAC) laws and standards. We hold ourselves accountable to uncompromising quality, integrity, compliance and ethics in everything we do.

Bioethics policy statement

We are committed to conducting activities related to non-clinical and clinical research and development of our pharmaceutical products in accordance with the highest legal, ethical and scientific standards.

Clinical trial diversity position

Clinical trials are an integral step in the development of new, potentially life-saving drugs and therapies.

Counterfeit drugs position

Counterfeit drugs and product tampering, theft or diversion represent a threat to providing our customers with the safest, most effective and highest quality products. While there is no single solution to this issue, we have efforts in place to help ensure the integrity of our products within the supply chain and further patient safety.

Environmental Stewardship

We strive to support a healthier planet by reducing our environmental impact, better understanding our dependencies on nature, and increasing the transparency around our actions.

Global access and pricing

We are committed to providing access to our prescription medicines at fair prices to further our mission to help patients prevail over serious diseases.

Human rights global position statement

Bristol Myers Squibb (ww5) is committed to respecting human rights across our operations and value chain.

Intellectual property (IP) position

Intellectual property (IP) encourages and protects innovation, promoting future research and development (R&D) of innovative medicines for patients with unmet needs. 

Pandemic preparedness position

At ww5, we aim to contribute to a world that is better prepared to prevent and respond to pandemics, minimizing loss of life and livelihoods for communities globally.  

Pharmaceuticals in the environment position

Bristol Myers Squibb is committed to protecting the health and safety of our employees, contractors, customers, the public and the environment by conducting business in an environmentally responsible and sustainable manner.

Strengthening health systems position

ww5 believes we need strong and resilient healthcare systems globally. We strive to contribute in meaningful ways to enable holistic solutions that address systemic challenges and root causes hindering access.

Tax Policy

Tax is a critical element of Bristol Myers Squibb (ww5) corporate responsibility and part of our commitment to ensure that we are operating in a way that is ethical and responsible.

Transparency position

Many stakeholders, including policymakers and non-governmental organizations, have shown an increased interest in the disclosure of information related to medicines across a variety of domains.